Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: A multivariable approach

International Journal of Stroke

Volumn 7, Issue 6, 2012, Pages 460-464

  Meyer, M ^a,b   Murie Fernandez, M ^a,c   Hall, R ^d   Liu, Y ^d   Fang, J ^d   Salter, K ^a   Foley, N ^a   Teasell, R ^a,b,e  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Cerebral infarction; Ischaemic stroke; Rehabilitation; Stroke; Thrombolysis; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CANADA; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; ONTARIO; REHABILITATION CENTERS; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84863992373     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00729.x     Document Type: Article

References (11)

1. Hall R, O'Callaghan C, Bayley M etal. Ontario Stroke Evaluation Report 2010: Technical Report. Available at 2010 (Accessed 3 Jan 2011).
2. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009; (4):CD000213.
3. Murray V, Norrving B, Sandercook PAG, Terent A, Wardlaw JM, Wester P. The molecular basis of thrombolysis and its clinical application in stroke. J Intern Med 2010; 267:191-208.
4. Demaerschalk BM. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Stroke 2007; 38:2215-2216.
5. Lindsay P, Bayley M, Hellings C etal. Canadian best practice recommendations for stroke care. CMAJ 2008; 179:s1-s25.
6. Silver FL, Kapral MK, Lindsay MP, Tu JV, Richards JA. International experience in stroke registries: lessons learned in establishing the Registry of the Canadian Stroke Network. Am J Prev Med 2006; 31:S235-S237.
7. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Acute stroke: prognosis and a prediction of the effect of medical treatment on outcome and health care utilization. The Copenhagen Stroke Study. Neurology 1997; 49:1335-1342.
8. Fagan SC, Morgenstern LB, Petitta A etal. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998; 50:883-890.
9. Meiner Z, Sajin A, Schwartz I etal. Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator. PM R 2010; 2:698-702.
10. Wade DT. Measurement in Neurological Rehabilitation. Oxford, Oxford University Press, 1994.
11. Stavem K, Lossius M, Ronning OM. Reliability and validity of the Canadian Neurological Scale in retrospective assessment of initial stroke severity. Cerebrovasc Dis 2003; 16:286-291.